| Improved survival with ipilimumab in patients with metastatic melanoma FS Hodi, SJ O'day, DF McDermott, RW Weber, JA Sosman, JB Haanen, ... New England Journal of Medicine 363 (8), 711-723, 2010 | 17028 | 2010 |
| Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology DS Ettinger, DE Wood, DL Aisner, W Akerley, J Bauman, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 15 (4), 504-535, 2017 | 1181 | 2017 |
| Percutaneous radiofrequency ablation of malignancies in the lung DE Dupuy, RJ Zagoria, W Akerley, WW Mayo-Smith, PV Kavanagh, ... American Journal of Roentgenology 174 (1), 57-59, 2000 | 874 | 2000 |
| Non–small cell lung cancer DS Ettinger, W Akerley, G Bepler, MG Blum, A Chang, RT Cheney, ... Journal of the national comprehensive cancer network 8 (7), 740-801, 2010 | 793 | 2010 |
| NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 19 (3), 254-266, 2021 | 786 | 2021 |
| Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022 | 704 | 2022 |
| NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines DS Ettinger, DE Wood, C Aggarwal, DL Aisner, W Akerley, JR Bauman, ... Journal of the National Comprehensive Cancer Network 17 (12), 1464-1472, 2019 | 668 | 2019 |
| Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non–small-cell lung cancer: Cancer and … EE Vokes, JE Herndon, MJ Kelley, MG Cicchetti, N Ramnath, H Neill, ... Journal of clinical oncology 25 (13), 1698-1704, 2007 | 580 | 2007 |
| Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer M Reck, A Luft, A Szczesna, L Havel, SW Kim, W Akerley, MC Pietanza, ... Journal of Clinical Oncology 34 (31), 3740-3748, 2016 | 513 | 2016 |
| NCCN guidelines insights: non–small cell lung cancer, version 5.2018 DS Ettinger, DL Aisner, DE Wood, W Akerley, J Bauman, JY Chang, ... Journal of the National Comprehensive Cancer Network 16 (7), 807-821, 2018 | 502 | 2018 |
| Non–small cell lung cancer, version 2.2013 DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 11 (6), 645-653, 2013 | 497 | 2013 |
| Small cell lung cancer GP Kalemkerian, W Akerley, P Bogner, H Borghaei, LQM Chow, ... Journal of the National Comprehensive Cancer Network 11 (1), 78-98, 2013 | 472 | 2013 |
| Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer LV Sequist, J Von Pawel, EG Garmey, WL Akerley, W Brugger, D Ferrari, ... J Clin Oncol 29 (24), 3307-3315, 2011 | 464 | 2011 |
| NCCN guidelines insights: non–small cell lung cancer, version 4.2016 DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ... Journal of the National Comprehensive Cancer Network 14 (3), 255-264, 2016 | 456 | 2016 |
| Non–small cell lung cancer DS Ettinger, W Akerley, H Borghaei, AC Chang, RT Cheney, LR Chirieac, ... Journal of the National Comprehensive Cancer Network 10 (10), 1236-1271, 2012 | 426 | 2012 |
| Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780 DM Savarese, S Halabi, V Hars, WL Akerley, ME Taplin, PA Godley, ... Journal of Clinical Oncology 19 (9), 2509-2516, 2001 | 408 | 2001 |
| Non–small cell lung cancer, version 6.2015 DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ... Journal of the National Comprehensive Cancer Network 13 (5), 515-524, 2015 | 400 | 2015 |
| High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? MJ Glantz, BF Cole, L Recht, W Akerley, P Mills, S Saris, F Hochberg, ... Journal of Clinical Oncology 16 (4), 1561-1567, 1998 | 364 | 1998 |
| Safety of bevacizumab in patients with non–small-cell lung cancer and brain metastases MA Socinski, CJ Langer, JE Huang, MM Kolb, P Compton, L Wang, ... Journal of Clinical Oncology 27 (31), 5255-5261, 2009 | 305 | 2009 |
| Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. H Choy, W Akerley, H Safran, S Graziano, C Chung, T Williams, B Cole, ... Journal of clinical oncology 16 (10), 3316-3322, 1998 | 302 | 1998 |
